
Neonatal Abstinence Syndrome Neonatal abstinence syndrome (NAS) is a group of prob- more to get a specific effect. When a drug is suddenly lems a neonate experiences when withdrawing from stopped, the body will show symptoms of withdrawal. narcotics (opioids) the neonate was exposed in utero. Fin- negan and MacNew were the first to describe the char- NAS has become a major health problem for neonates acteristics of the infant born to the narcotic-dependent born in the United States. In 2012, Patrick and colleagues mother, using the term NAS to express the cluster of did a retrospective, cross-sectional analysis of neonates symptoms affecting the central nervous, autonomic ner- diagnosed with NAS from 2000–2009 in the United vous, gastrointestinal, and respiratory systems (Finnegan States to determine the incidence and healthcare costs & MacNew, 1974). Although the presentation of NAS can associated with the diagnosis. They found that the be variable, withdrawal symptoms most commonly seen number of neonates diagnosed with NAS almost tripled in neonates are tremors, irritability, decreased sleep inter- during that time from 1.2 per 1,000 live births to 3.39 vals, high-pitched crying, increased muscle tone, hyper- per 1,000 live births. A follow-up study examined the active reflexes, poor feeding, abnormal/constant suck, incidence from 2009 to 2012 and found that the incidence diarrhea, dehydration, poor weight gain, fever, mot- doubled in this 3-year period. In 2012, the national tling, and temperature instability (Hudak & Tan, 2012). average of babies being diagnosed with NAS was 5.8 Hudak and Tan (2012) also note that onset of NAS symp- per 1,000 live births, or one baby born every 25 minutes toms vary depending on the drug(s) the mother abused (Patrick, Davis, Lehmann, & Cooper, 2015). The authors during her pregnancy, the timing of the last dose, mater- also noted that there was great regional variation of nal metabolism, placental transport of the medication, NAS in the United States, ranging from of 3.0 per 1,000 and neonatal metabolism and excretion. The closer to live births in the Pacific Northwest to 16.2 per 1,000 live the time of delivery the drug was consumed, the later the births in the East South Central (Patrick et al., 2015). signs of withdrawal will occur. In general, withdrawal will occur from 24 hours after birth for heroin to up to The costs associated with the increased length of stay 72 hours for methadone. There are cases in which with- for the NAS baby also have increased since 2009. In 2009 drawal did not occur for up to 96 hours or more after the average hospital cost was $53,400; by 2012 that cost birth. NAS symptoms can last up to 8–16 weeks of age had increased to $66,700, which is 19 times higher than for some neonates. It also is important to note that with- the average hospital stay for a healthy term neonate of drawal symptoms are more severe for neonates whose $3,500 (Patrick et al., 2015). This translated into $1.4 mothers were chronic abusers and milder for premature billion in total hospital expenses in 2012, which had infants. doubled since 2009 and is mostly attributed to Medicaid dollars (Patrick et al., 2015). Neonates diagnosed with NAS are not born addicted to medications but are dependent to the medications The diagnosis of NAS begins with obtaining a history that they were exposed to in utero. The difference from the mother on her drug use during pregnancy. This between addiction and dependence, according to the history needs to include both prescription and over-the- National Institute of Drug Abuse, is that addiction is the counter medications, herbal use, illicit drug use, smoking compulsive drug use despite the negative consequences habits, and alcohol usage. When obtaining the history on the person’s family, social, and work life (National from the mother, maintain a nonjudgmental attitude and Institute of Drug Abuse, 2013). Dependence is when the conduct the interview in a private setting away from body acclimates to the drug that is being taken, requiring other family members or friends, using motivational interviewing techniques. 264 Baby Steps to Home © 2018 by the National Association of Neonatal Nurses Diagnoses It is very important to do the interview away from fam- The umbilical cord is the newest method for drug testing ily members, especially the significant other, as many in a newborn. The umbilical cord can be collected at the times they are unaware of the drug usage. When inter- time of birth and stored up to 7 days of age, if prepared viewing the mother, it is of utmost importance to make properly. The cord sample needs to be 6 in. in length clear to the mother that the objective behind asking the and is prepared by draining the blood from the cord and questions is to be able to determine the best way to care rinsing the specimen in the solution recommended by the for the neonate, not to punish the mother. If the mother drug testing company. The cord, like meconium, will give admits drug use, the following information needs to be information on drug use during the last two trimesters of documented: the drug use, amount of drug(s) used, the pregnancy. route of use, the duration of use, and any history of a drug treatment program. Questions about family member drug, Physical signs and symptoms of NAS were described ear- alcohol, or smoking habits also are important to docu- lier and will vary depending on the neonate, the drugs he ment. Many women will not admit their own drug use but or she was exposed to, the timing of the last dose, and will admit to their partner or husband’s drug use. the gestational age of the neonate. Assessment tools have been developed by several authors to assist with Diagnosis of the infant can be done by testing the infant’s assessing the severity of the signs and symptoms and urine, hair, meconium, or umbilical cord for drugs. Urine response to the NAS treatment. The Neonatal Absti- testing is the least accurate of the tests, as urine only nence Scoring System (NASS), developed by Dr. Loretta detects recent use of a drug. Depending on the drug used Finnegan in 1975, was the first scoring tool, and is com- and the timing of the last dose from when the urine is monly referred to as the Finnegan Scoring Tool (Fin- obtained, the infant’s urine can be negative, even though negan, Connaughton, Kron, & Emich, 1975). This is the the mother admitted to drug use. Hair, meconium, and the most widely used NAS tool in NICUs in the United States umbilical cord all show what drugs were taken during the today, despite the tool only recently being validated for last one to two trimesters of the pregnancy. reliability. Other scoring tools available that are consid- ered reliable and valid are the Lipsitz tool (Lipsitz, 1975), Hair is not used often because a 2 mg–5 mg of hair is the Neonatal Narcotic Withdrawal Index (Green & Suffet, needed to test for drug usage, and either the babies 1981), and the Neonatal Withdrawal Inventory (Zahorondy do not have enough hair or the healthcare providers do et al., 1998). All of the tools assess what the author of not like to remove hair for testing. The majority of hair the tool believes to be the most common signs and symp- grows in the last trimester so a hair sample will detect toms of NAS and assign the symptom a score. The symp- usage in the last trimester of pregnancy. If using hair toms vary from 8 for the Neonatal Withdrawal Inventory for drug sampling, it is important to get the hair sample to 21 for the Finnegan Scoring Tool. prior to discharge from the hospital as environmental contamination can affect the test results. For a neonate diagnosed with NAS, nonpharmaco- logical interventions are instituted first; if they do not Meconium is relative easy to collect, but to get an help to alleviate symptoms, pharmacotherapy will be accurate test, the entire meconium column needs to ordered next. Nonpharmacological interventions such be collected from the first stool to the first transitional as decreased light and noise levels, skin-to-skin care, stool. The different meconium samples collected in one and swaddling have been shown to help the infant diag- collection container need to be thoroughly mixed prior to nosed with NAS. A complete list is described in Table sending them to the lab to be tested. Most labs will only 1. Many babies with NAS have difficulty with feeding. take one or two samples at the most and depending on Nursing interventions such as offering small frequent which sample they test, the test can come back negative feeds, not talking to the infant when feeding so the baby even though the infant is positive. can focus on eating, occasional gavage feeds, offering a 265 Baby Steps to Home © 2018 by the National Association of Neonatal Nurses Diagnoses higher caloric milk so a decreased volume can be given, Tan, 2012). Despite this recommendation, breastfeeding and encouraging breastfeeding for those neonates whose rates remain low, but it should be encouraged in this pop- mothers are in treatment programs have been shown to ulation of women and infants. Several studies show that help with the NAS symptoms. infants with NAS who are breastfed or receive breast milk (breast or bottle) for more than 75% of their feeds have decreased severity of symptoms, lower use of phar- Table 1 – Nonpharmacologic Interventions macologic agents, and decreased length of stay, as well • Swaddling—in a flexed position with hands midline as increased maternal attachment (Jansson et al., 2008; against chest and legs loosely swaddled in lumbar flexion—to decrease sensory stimulation McQueen, Murphy-Oikonen, Gerlach, & Montelpare, • Minimize environmental and physical stimulation—low 2011; Pritham, Paul, & Hayes, 2012; Hodgson & Abra- lighting and noise level—do not use TV or mobiles hams, 2012; Welle-Strand et al., 2013; Crillo & Francis, • Avoidance of abrupt changes in infant’s environment— 2016; Holmes, Schmidlin, & Kurzum, 2017).
Details
-
File Typepdf
-
Upload Time-
-
Content LanguagesEnglish
-
Upload UserAnonymous/Not logged-in
-
File Pages8 Page
-
File Size-